Home > A. Molecular pathology > Targeted therapy > anti-IL-6 drugs
anti-IL-6 drugs
Monday 2 January 2012
| Wikipedia |
Anti-interleukin-6 agents are a recent class of therapeutics.
Interleukin-6 is relevant to many inflammatory diseases and many cancers. Hence anti-IL-6 agents have been sought.
Types
tocilizumab (Actemra)
In clinical trials
- esilimomab for some cancers
- CNTO-328
- ALD-518
- CNTO-136
- CPSI-2364[6], CDP6038[7].
- VX30
- ARGX-109
- FE301
FM101
